We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
GB Sciences Inc (PK) | USOTC:GBLX | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.0003 | -4.41% | 0.0065 | 0.0062 | 0.0074 | 0.0065 | 0.0062 | 0.0062 | 12,342 | 21:00:06 |
Mr. Ellins stated, "We are all very pleased to have caught the attention of so many highly respected media outlets and to be recognized as an expert in the medical marijuana industry. This interest is a testament to the quality of our science, technology, management team and our ability to continue executing our business plan."
GrowBLOX Sciences, Inc. and CEO Craig Ellins were the focal point of an article published by www.MainStreet.com titled Cannabis Dispensary in Nevada Secures Banking Account. Read the entire article here: http://www.mainstreet.com/article/small-business/cannabis-dispensary-nevada-secures-banking-account?page=1.
Craig Ellins was also recently quoted in an article by the International Business Times titled Industrial Hemp Research and Production on the Rise After New Legislation. Read the entire article here: http://www.ibtimes.com/industrial-hemp-research-production-rise-after-new-legislation-1629176.
Mr. Ellins has conducted several interviews being labeled as an industry expert in the past couple weeks which will lead to additional articles, quotes, and high quality media placements. Mr. Ellins continued, "We hope the increased media attention will not only help educate people on the exciting things happening with GrowBLOX Sciences, Inc., but increase awareness and understanding by the medical marijuana community as to what it truly means to produce a safe, consistent, and effective medicine for patients."
The Company plans to update shareholders and the investment community as several of the interviews are expected to be published within the next one to two weeks.
About GrowBLOX Sciences, Inc.
GrowBLOX Sciences, Inc., is a research and biotechnical company that has developed proprietary indoor growing chambers specifically designed for medical cannabis cultivation. The GrowBLOX chamber allows for completely controlled growing conditions, ensuring the manufacture of a consistent, toxin-free, natural and medicinal-grade product. The Company believes that the advantages of a controlled environment over traditional outdoor or greenhouse growing, will empower the public, nutraceutical and pharmaceutical industries to embrace cannabis as an effective treatment for a myriad of serious medical conditions. http://www.gbsciences.com
Forward-Looking Statements
Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are inherently unreliable and actual results may differ materially. Examples of forward-looking statements in this news release include statements regarding the payment of dividends, marketing and distribution plans, development activities and anticipated operating results. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as the Company's ability to accomplish its business initiatives, significant fluctuations in marketing expenses and ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of its products and services, as well as the introduction of competing products, or management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other information that may be detailed from time to time in the Company's filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACT: Jonathan Barkman Riverview Capital Enterprises +1-866-845-0105
1 Year GB Sciences (PK) Chart |
1 Month GB Sciences (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions